StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) says FDA delaying decision on RSV vaccine approval, shares fall
May 10, 2024 9:33 AM
Moderna (NASDAQ: MRNA) shares are down just over 1% in early Friday trading after the company said the FDA has ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Hot List
Next Articles
Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
May 10, 2024 7:42 AM
Moderna (MRNA) Issues Update on Investigational RSV Vaccine
May 10, 2024 7:07 AM
Moderna Announces Update on Investigational RSV Vaccine
May 10, 2024 7:03 AM
Moderna (MRNA) PT Raised to $85 at Deutsche Bank
May 9, 2024 11:51 AM
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management
May 9, 2024 7:00 AM
Form 8-K Moderna, Inc. For: May 06
May 9, 2024 6:02 AM
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
May 8, 2024 4:24 PM
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
May 8, 2024 8:30 AM
